1. Identifying menopause in breast cancer patients: considerations and implications

   • Mark Clemons
   • Christine Simmons

   Review Paper 24 October 2006 Pages: 115 - 120

   

2. The role of ATM in breast cancer development

   • Jana Prokopcova
   • Zdenek Kleibl
   • Petr Pohlreich

   Review Paper 24 October 2006 Pages: 121 - 128

   

3. Focused antibody response in plasma cell-infiltrated non-medullary (NOS) breast cancers

   • Y. Wang
   • F. Ylera
   • R. P. Junghans

   Clinical Trial 28 March 2007 Pages: 129 - 144

   

4. A cognitive behavioral therapy intervention to promote weight loss improves body composition and blood lipid profiles among overweight breast cancer survivors

   • Kari Mefferd
   • Jeanne F. Nichols
   • Cheryl L. Rock

   Clinical Trial 21 October 2006 Pages: 145 - 152

5. MDM2 SNP309 accelerates familial breast carcinogenesis independently of estrogen signaling

   • Marijke Wasielewski
   • Jord H. A. Nagel
   • Mieke Schutte

   Epidemiology 02 November 2006 Pages: 153 - 157

   

6. A multigenic approach to predict breast cancer risk

   • Armin Gerger
   • Uwe Langsenlehner
   • Peter Krippl

   Epidemiology 21 October 2006 Pages: 159 - 164

   

7. Protein Kinase C α is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells

   • Lisa B. Frankel
   • Anne E. Lykkesfeldt
   • Jan Stenvang

   Original Paper 24 October 2006 Pages: 165 - 179

   

8. MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status

   • Tone F. Bathen
   • Line R. Jensen
   • Steinar Lundgren

   OriginalPaper 24 October 2006 Pages: 181 - 189

   

9. Proteomic analysis of nipple aspirate fluid throughout the menstrual cycle in healthy pre-menopausal women

   • Jillian Noble
   • R. Sascha Dua
   • Clare M. Isacke

   Original Paper 24 October 2006 Pages: 191 - 196

   

10. Genetic variation in IGF1, IGFBP3, IRS1, IRS2 and risk of breast cancer in women living in Southwestern United States

    • M. L. Slattery
    • C. Sweeney
    • T. Byers

    Original Paper 19 October 2006 Pages: 197 - 209

11. Inhibition of steroid sulfatase activity and cell proliferation in ZR-75-1 and BT-474 human breast cancer cells by KW-2581 in vitro and in vivo

    • Hiroyuki Ishida
    • Taisuke Nakata
    • Shiro Akinaga

    Original Paper 24 October 2006 Pages: 211 - 219

    

12. Lycopene and other carotenoids inhibit estrogenic activity of 17β-estradiol and genistein in cancer cells

    • Keren Hirsch
    • Andrea Atzmon
    • Yoav Sharoni

    Original Paper 19 October 2006 Pages: 221 - 230

    

13. Revised Abstracts San Antonio Breast Cancer Symposium 2006

    Abstract 04 July 2007 Pages: 231 - 231